Catch up on the top radiology content of the past week.
|Articles|August 19, 1998
Caprius inks breast MRI deal with MGH
MR mammography vendor Caprius of Wilmington, MA, announced this month an agreement with Massachusetts General Hospital of Boston to install the company's Aurora system at the hospital's breast imaging division. The agreement is part of Caprius' program
Advertisement
MR mammography vendor Caprius of Wilmington, MA, announced this month an agreement with Massachusetts General Hospital of Boston to install the company's Aurora system at the hospital's breast imaging division. The agreement is part of Caprius' program to partner with hospitals in revenue-sharing agreements based on Aurora usage, and Caprius and MGH will equally share the technical fee for each scan. The MGH deal is the company's sixth joint venture in the U.S. and brings the firm into partnership with the hospital's well-known director of breast imaging, Dr. Daniel Kopans. In other Caprius news, the company in April won credit lines worth up to $3.2 million, which it expects to use to fund installations of Aurora (SCAN 4/15/98).
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5